San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors ...

Researchers have identified a key weakness in acute myeloid leukemia, offering a promising new strategy to delay the ...

Advances in drug discovery, coupled with regulatory approvals for novel drugs like inotuzumab for acute lymphoblastic leukemia, underscore the industry ... regulatory agencies contribute to the timely ...

The technology accurately detects the presence of these gene fusions in acute promyelocytic leukemia ... Radon, Even at Levels Below EPA Guideline for Mitigation, Is Linked to Childhood Leukemia ...

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today ...

The FDA approved zolbetuximab (Vyloy) on October 18, 2024, as a first-line treatment for locally advanced unresectable or ...

Harvey Weinstein, the disgraced Hollywood mogul whose alleged sexual misconduct fueled the #MeToo movement and who was recently indicted on new charges, has chronic myeloid leukemia, two sources ...

For children with acute lymphoblastic leukemia (ALL), measurable residual disease (MRD) after the end of first consolidation (EOC) can be used to predict the need for subsequent MRD measurements ...

Acute myeloid leukemia (AML) is a blood cell cancer that is estimated to cause ∼100,000 deaths worldwide each year. (1) Current standard of care includes treatment with chemotherapeutic agents, newer ...